← Back to Treatments
🏅 FDA Orphan Designation

URSO 250

Ursodiol

Manufacturer: Aptalis Pharma US, Inc.

Indicated for:
Primary biliary cholangitisOrphan

FDA-Approved Indications (1)

Primary biliary cholangitisOrphan Designation

Indications & Usage

1 INDICATIONS AND USAGE URSO 250 and URSO Forte (ursodiol) tablets are indicated for the treatment of patients with primary biliary cholangitis (PBC). URSO 250 and URSO Forte (ursodiol) tablets are bile acids indicated for the treatment of patients with primary biliary cholangitis. ( 1 )

💙 Support Programs

View all →
URSO 250
Aptalis Pharma US, Inc.
Ursodiol
AvKARE
Ursodiol 200 mg, Ursodiol 400 mg
Travere

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.